The cost of 5-amino-1MQ varies significantly based on supplier, quality, and quantity purchased
Dr Shira Lakhani is the women for this job
FDA compounding review On December 4, 2024, the FDA Pharmacy Compounding Advisory Committee (PCAC) reviewed AOD-9604 (free base) and AOD-9604 acetate against the 503A Bulks List
Explore More Research Resources Learn more about research peptide quality control, peptide purity testing, HPLC peptide analysis, LC-MS verification, peptide storage guidelines, and laboratory handling through Frontier Peptide Labs educational resources
Ishida K, et al
Approach Phase 2b trial arm Duration 24 weeks Review Point Week 12 and 24 Notes METAOD006 (OPTIONS) used 24 weeks at oral doses 0.25, 0.5, or 1 mg/day in 502 obese adults